1.Dietary intake of n-3 and n-6 polyunsaturated fatty acids in Korean toddlers 12–24 months of age with comparison to the dietary recommendations
Youjin KIM ; Hyesook KIM ; Oran KWON
Nutrition Research and Practice 2019;13(4):344-351
BACKGROUND/OBJECTIVES: Adequate dietary fatty acid intake is important for toddlers between 12–24 months of age, as this is a period of dietary transition in conjunction with rapid growth and development; however, actual fatty acid intake during this period seldom has been explored. This study was conducted to assess the intake status of n-3 and n-6 polyunsaturated fatty acids by toddlers during the 12–24-month period using 2010–2015 Korea National Health and Nutrition Examination Survey data. SUBJECTS/METHODS: Twenty-four-hour dietary recall data of 12–24-month-old toddlers (n = 544) was used to estimate the intakes of α-linolenic acid (ALA; 18:3n-3), eicosapentaenoic acid (EPA; 20:5n-3), docosahexaenoic acid (DHA; 22:6n-3), linoleic acid (LA; 18:2n-6), and arachidonic acid (AA; 20:4n-6), as well as the major dietary sources of each. The results were compared with the expected intake for exclusively breastfed infants in the first 6 months of life and available dietary recommendations. RESULTS: Mean daily intakes of ALA, EPA, DHA, LA, and AA were 529.9, 22.4, 37.0, 3907.6, and 20.0 mg/day, respectively. Dietary intakes of these fatty acids fell below the expected intake for 0–5-month-old exclusively breastfed infants. In particular, DHA and AA intakes were 4 to 5 times lower. The dietary assessment indicated that the mean intake of essential fatty acids ALA and LA was below the European and the FAO/WHO dietary recommendations, particularly for DHA, which was approximately 30% and 14–16% lower, respectively. The key sources of the essential fatty acids, DHA, and AA were soy (28.2%), fish (97.3%), and animals (53.7%), respectively. CONCLUSIONS: Considering the prevailing view of DHA and AA requirements on early brain development, there remains considerable room for improvement in their intakes in the diets of Korean toddlers. Further studies are warranted to explore how increasing dietary intakes of DHA and AA could benefit brain development during infancy and early childhood.
Animals
;
Arachidonic Acid
;
Brain
;
Diet
;
Eicosapentaenoic Acid
;
Fatty Acids
;
Fatty Acids, Essential
;
Fatty Acids, Unsaturated
;
Growth and Development
;
Humans
;
Infant
;
Korea
;
Linoleic Acid
;
Nutrition Surveys
2.Therapeutic Effects of Amino Acids in Liver Diseases: Current Studies and Future Perspectives
Journal of Cancer Prevention 2019;24(2):72-78
Hepatocellular carcinoma (HCC) is the most common primary malignant tumor of the liver and the third most common cause of cancer-related death worldwide. HCC is caused by infection of hepatitis B/C virus and liver dysfunctions, such as alcoholic liver disease, nonalcoholic fatty liver disease, and cirrhosis. Amino acids are organic substances containing amine and carboxylic acid functional groups. There are over 700 kinds of amino acids in nature, but only about 20 of them are used to synthesize proteins in cells. Liver is an important organ for protein synthesis, degradation and detoxification as well as amino acid metabolism. In the liver, there are abundant non-essential amino acids, such as alanine, aspartate, glutamate, glycine, and serine and essential amino acids, such as histidine and threonine. These amino acids are involved in various cellular metabolisms, the synthesis of lipids and nucleotides as well as detoxification reactions. Understanding the role of amino acids in the pathogenesis of liver and the effects of amino acid intake on liver disease can be a promising strategy for the prevention and treatment of liver disease. In this review, we describe the biochemical properties and functions of amino acids and to review how they have been applied to treatment of liver diseases.
Alanine
;
Amino Acids
;
Amino Acids, Essential
;
Aspartic Acid
;
Carcinoma, Hepatocellular
;
Fibrosis
;
Glutamic Acid
;
Glycine
;
Hepatitis
;
Histidine
;
Liver Diseases
;
Liver Diseases, Alcoholic
;
Liver
;
Metabolism
;
Non-alcoholic Fatty Liver Disease
;
Nucleotides
;
Serine
;
Therapeutic Uses
;
Threonine
3.Evening Primrose (Oenothera biennis) Oil in Management of Female Ailments
Journal of Menopausal Medicine 2019;25(2):74-82
Oenothera biennis with the common name of “evening primrose” is containing a valuable fixed oil with commercial name of EPO. Evening primrose oil has two types of omega-6-fatty acid including linoleic acid (60%–80%) and γ-linoleic acid (8%–14%). Essential fatty acids are considered as essential compounds for body health, especially among women. The aim of this study was to evaluate the efficacy of evening primrose oil in the management of women ailments. The document was prepared by investigation in scientific articles of electronic resources (Google Scholar, PubMed, Science Direct, Wiley, Scopus, and Springer) by keywords of evening primrose oil and women. The results of our investigations showed that evening primrose oil has been the subject of several clinical studies, including premenstrual syndrome (PMS), hot flash, mastalgia, fibroadenomas, gestational diabetes, cervical ripening, and dilation. The major clinical studies are focused on mastalgia, followed by PMS. The results of studies confirmed the evening primrose oil's efficacy in women health, but the immediate response should not be expected from it, therefore, it should be regularly used up to 4 or 6 months.
Cervical Ripening
;
Diabetes, Gestational
;
Fatty Acids, Essential
;
Female
;
Fibroadenoma
;
Humans
;
Linoleic Acid
;
Mastodynia
;
Oenothera biennis
;
Pregnancy
;
Premenstrual Syndrome
4.Current Practice Pattern for Dry Eye Patients in South Korea: A Multicenter Study.
Jong Suk SONG ; Joon Young HYON ; Doh LEE ; Euisang CHUNG ; Chulyoung CHOI ; Jeongbok LEE ; Hyo Myung KIM
Korean Journal of Ophthalmology 2014;28(2):115-121
PURPOSE: To assess current practice patterns for dry eye patients in South Korea and to evaluate the preference according to the ages and clinic types of physicians. METHODS: Dry eye patients (n = 1,612) were enrolled in this multicenter cross-sectional, observational study. The severity level of dry eye patients was classified based on the Korean guidelines for dry eye treatment. The medical records of the enrolled dry eye patients were evaluated, and the practice styles and the preferences were analyzed according to the ages and clinic types of physicians. RESULTS: Of all patients, dry eye level 1 was most common (47.5%), followed by level 2 (33.5%), level 3 (9.1%), and level 4 (1.1%). Topical anti-inflammatory agents were used in 70.7% of patients with dry eye level 2 and in 80.6% of patients at levels 3 and 4. Topical anti-inflammatory agents were also used in 48.7% of patients with dry eye level 1. Preservative-free artificial tears were preferred at all dry eye levels. The use of topical anti-inflammatory agents did not differ with investigator ages, but older physicians preferred preserved artificial tears more than younger ones. Physicians at referral hospitals also tended to use topical anti-inflammatory agents and preservative-free artificial tears earlier, beginning at dry eye level 1, than those who worked at private eye clinics. CONCLUSIONS: Topical anti-inflammatory agents were commonly prescribed for the treatment of dry eye patients in South Korea, even from dry eye level 1. Preservative-free artificial tears were preferred at all dry eye levels. Practice styles differed somewhat depending on the ages and clinic types of physicians.
Adult
;
Age Factors
;
Aged
;
Aged, 80 and over
;
Anti-Inflammatory Agents/*therapeutic use
;
Attitude of Health Personnel
;
Cross-Sectional Studies
;
Cyclosporine/*therapeutic use
;
Dry Eye Syndromes/*drug therapy
;
Fatty Acids, Essential/therapeutic use
;
Female
;
Humans
;
Lubricant Eye Drops/*therapeutic use
;
Male
;
Middle Aged
;
Ointments/therapeutic use
;
Ophthalmology/*standards
;
Practice Guidelines as Topic
;
*Professional Practice
;
Referral and Consultation
;
Republic of Korea
;
Severity of Illness Index
;
Young Adult
5.Adequacy of Lipid Emulsion Administration Prescription Rate in a Single Center.
Hye Ryun JUNG ; Myoung On EUN ; Eun Sook BANG ; Ji Hyun LEE ; Mi Hyang KIM ; Jeong HONG ; Eun Jung PARK ; Jae Myeong LEE
Journal of Clinical Nutrition 2014;6(3):108-113
PURPOSE: IV-lipid emulsion can be a nutritional supplement to provide essential fatty acids and energy for patients who need total parenteral nutrition support. The recommended administration dose of lipid emulsion is less than 2.5 g/kg/d and the rate should not exceed 0.15 g/kg/h for adult patients. The purpose of this study is to evaluate the adequacy of the currently prescribed administration rate of IV-lipid emulsion in a single center. METHODS: We analyzed 1,739 lipid emulsion administration prescriptions in 1,095 patients over 18 years old at Ajou University Hospital from January 1, 2014 to March 31. RESULTS: The median prescription rate of total lipid emulsion was 0.134 (0.012~1.125) g/kg/h, and the exceeding portion of maximum recommended infusion rate was 36.9%. The median administration prescription rate of lipid emulsion was faster in 500 mL emulsions, compared to 250 mL emulsion (0.146 g/kg/h vs. 0.075 g/kg/h; P<0.001) and at emergency room (ER), compared to general ward (0.154 g/kg/h vs. 0.123; P<0.001). The exceeding portion of maximum recommended infusion rate of lipid emulsion was also higher in 500 mL emulsion, compared to 250 mL emulsion (52.2% vs. 30.4%; P<0.001) and at ER, compared to general ward (52.1% vs. 30.4%; P<0.001). Triglyceride level was higher in exceeding recommended infusion rate compared to less, but not statistically significant (119 mg/dL vs. 261 mg/dL; P=0.202). CONCLUSION: Administration prescription rate of lipid emulsion exceeded the recommended rate and this feature was dominant in 500 mL emulsion and at ER. Education and monitoring of lipid emulsion prescription is needed for appropriate lipid administration and prevention of fat overload syndrome.
Adult
;
Education
;
Emergency Service, Hospital
;
Emulsions
;
Fatty Acids, Essential
;
Humans
;
Parenteral Nutrition, Total
;
Patients' Rooms
;
Prescriptions*
;
Triglycerides
6.The Stimulatory Effect of Essential Fatty Acids on Glucose Uptake Involves Both Akt and AMPK Activation in C2C12 Skeletal Muscle Cells.
So Yeon PARK ; Min Hye KIM ; Joung Hoon AHN ; Su Jin LEE ; Jong Ho LEE ; Won Sik EUM ; Soo Young CHOI ; Hyeok Yil KWON
The Korean Journal of Physiology and Pharmacology 2014;18(3):255-261
Essential fatty acid (EFA) is known to be required for the body to function normally and healthily. However, the effect of EFA on glucose uptake in skeletal muscle has not yet been fully investigated. In this study, we examined the effect of two EFAs, linoleic acid (LA) and alpha-linolenic acid (ALA), on glucose uptake of C2C12 skeletal muscle cells and investigated the mechanism underlying the stimulatory effect of polyunsaturated EFAs in comparison with monounsaturated oleic acid (OA). In palmitic acid (PA)-induced insulin resistant cells, the co-treatment of EFAs and OA with PA almost restored the PA-induced decrease in the basal and insulin-stimulated 2-NBDG (fluorescent D-glucose analogue) uptake, respectively. Two EFAs and OA significantly protected PA-induced suppression of insulin signaling, respectively, which was confirmed by the increased levels of Akt phosphorylation and serine/threonine kinases (PKCtheta and JNK) dephosphorylation in the western blot analysis. In PA-untreated, control cells, the treatment of 500 microM EFA significantly stimulated 2-NBDG uptake, whereas OA did not. Phosphorylation of AMP-activated protein kinase (AMPK) and one of its downstream molecules, acetyl-CoA carboxylase (ACC) was markedly induced by EFA, but not OA. In addition, EFA-stimulated 2-NBDG uptake was significantly inhibited by the pre-treatment of a specific AMPK inhibitor, adenine 9-beta-D-arabinofuranoside (araA). These data suggest that the restoration of suppressed insulin signaling at PA-induced insulin resistant condition and AMPK activation are involved at least in the stimulatory effect of EFA on glucose uptake in C2C12 skeletal muscle cells.
Acetyl-CoA Carboxylase
;
Adenine
;
alpha-Linolenic Acid
;
AMP-Activated Protein Kinases*
;
Blotting, Western
;
Fatty Acids, Essential*
;
Glucose*
;
Insulin
;
Linoleic Acid
;
Muscle, Skeletal*
;
Oleic Acid
;
Palmitic Acid
;
Phosphorylation
;
Phosphotransferases
7.Polyunsaturated Fatty Acids in Children.
Pediatric Gastroenterology, Hepatology & Nutrition 2013;16(3):153-161
Polyunsaturated fatty acids (PUFAs) are the major components of brain and retina, and are the essential fatty acids with important physiologically active functions. Thus, PUFAs should be provided to children, and are very important in the brain growth and development for fetuses, newborn infants, and children. Omega-3 fatty acids decrease coronary artery disease and improve blood flow. PUFAs have been known to have anti-inflammatory action and improved the chronic inflammation such as auto-immune diseases or degenerative neurologic diseases. PUFAs are used for metabolic syndrome related with obesity or diabetes. However, there are several considerations related with intake of PUFAs. Obsession with the intake of unsaturated fatty acids could bring about the shortage of essential fatty acids that are crucial for our body, weaken the immune system, and increase the risk of heart disease, arrhythmia, and stroke. In this review, we discuss types, physiologic mechanism of action of PUFAs, intake of PUFAs for children, recommended intake of PUFAs, and considerations for the intake of PUFAs.
Arrhythmias, Cardiac
;
Brain
;
Child
;
Coronary Artery Disease
;
Fatty Acids, Essential
;
Fatty Acids, Omega-3
;
Fatty Acids, Unsaturated
;
Fetus
;
Growth and Development
;
Heart Diseases
;
Humans
;
Immune System
;
Infant, Newborn
;
Inflammation
;
Neurodegenerative Diseases
;
Obesity
;
Obsessive Behavior
;
Retina
;
Stroke
8.Systematic review of the effect of omega-3 fatty acids on improvement of blood flow while focused on evaluation of claims for health functional food.
Sewon JEONG ; Ji Yeon KIM ; Ju Eun PAEK ; Joohee KIM ; Jin Sook KWAK ; Oran KWON
Journal of Nutrition and Health 2013;46(3):226-238
Omega-3 polyunsaturated fatty acids are essential fatty acids because humans cannot synthesize them de novo and must obtain them in their diet. Fish and fish oil are rich sources of omega-3 fatty acids, including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Significant evidence of the beneficial role of dietary intake of omega-3 fatty acids in blood flow has been reported and putative mechanisms for improvement of blood flow include anti-thrombotic effects, lowered blood pressure, improved endothelial function, and anti-atherogenic effects. Edible oils containing omega-3 fatty acids were registered as functional ingredients in the Korea Health Functional Food Code. Although omega-3 fatty acids have been evaluated by the Korea Food and Drug Administration (KFDA) based on scientific evidence, periodic re-evaluation may be needed because emerging data related to omega-3 fatty acids have accumulated. Therefore, in this study, we re-evaluated scientific evidence for the effect of omega-3 fatty acids as a functional ingredient in health functional food on improvement of blood flow. A comprehensive literature search was conducted for collection of relevant human studies using the Medline and Cochrane, KISS, and IBIDS databases for the years 1955-2012. Search keywords were used by combination of terms related to omega-3 fatty acids and blood flow. The search was limited to human studies published in Korean, English, and Japanese. Using the KFDA's evidence based evaluation system for scientific evaluation of health claims, 112 human studies were identified and reviewed in order to evaluate the strength of the evidence supporting a relation between omega-3 fatty acids and blood flow. Among 112 studies, significant effects on improvement of blood flow were reported in 84 studies and the daily intake amount was ranged from 0.1 to 15 g. According to this methodology of systematic review, we concluded that there was possible evidence to support a relation between omega-3 fatty acid intake and blood flow. However, because inconsistent results have recently been reported, future studies should be monitored.
Asian Continental Ancestry Group
;
Blood Pressure
;
Diet
;
Eicosapentaenoic Acid
;
Fatty Acids, Essential
;
Fatty Acids, Omega-3
;
Fatty Acids, Unsaturated
;
Functional Food
;
Humans
;
Korea
;
Oils
;
United States Food and Drug Administration
9.Omega-3 and Menopause.
Tae Hee KIM ; Dong Won BYUN ; Yongsoon PARK
The Journal of Korean Society of Menopause 2012;18(2):75-80
Menopause is a turning point in women that is based on the sex hormone change. Many women are very conscious about the postmenopausal period. After menopause, women complain about vasomotor symptoms, night sweat, psychological problems, osteoporosis, cardiovascular disease and urogenital symptoms. Nowadays, food and alternative treatment for postmenopausal symptoms are introduced. The average life span is now increasing, and postmenopausal care is important for public health. Long chain omega-3 and omega-6 fatty acids are known as essential fatty acids, however, all mammals, including humans, should obtain them from their diet. Omega-3 fatty acids have emerged as an adjuvant and alternative source for relieving postmenopusal complains or disease. Among alternative treatment or food behavior change for postmenopusal symptoms, we will review the current issues on the relationship between the role and the effect of omega-3 fatty acids in relieving postmenopausal symptoms.
Cardiovascular Diseases
;
Diet
;
Fatty Acids, Essential
;
Fatty Acids, Omega-3
;
Fatty Acids, Omega-6
;
Female
;
Humans
;
Mammals
;
Menopause
;
Osteoporosis
;
Postmenopause
;
Public Health
;
Sweat
10.Effects of Omega-3 Fatty Acid during Pregnancy.
Korean Journal of Perinatology 2012;23(1):1-4
Omega-3-fatty acids (FA) are essential fatty acids with various biological effects in human health and disease. Dietary supplementation may benefit patients with cardiovascular disease, dyslipidemia, atherosclerosis, hypertension, diabetes mellitus, metabolic syndrome, obesity, inflammatory disease, neurological disorders, and eye diseases. Especially, consumption of omega-3-FAs during pregnancy reduces the risk of preterm birth and improves intellectual development of the fetus. Fish, fish oils and some vegetable oils are rich sources of omega-3-FAs. According to World Health Organization (2003) guidelines, a healthy adult should consume two fish meals in a week (400-1,000 mg eicosapentanoic acid+docosahexanoic acid) to obtain the health benefit.
Adult
;
Atherosclerosis
;
Cardiovascular Diseases
;
Diabetes Mellitus
;
Dietary Supplements
;
Dyslipidemias
;
Eye Diseases
;
Fatty Acids, Essential
;
Fetus
;
Fish Oils
;
Humans
;
Hypertension
;
Insurance Benefits
;
Meals
;
Nervous System Diseases
;
Obesity
;
Plant Oils
;
Pregnancy
;
Premature Birth
;
World Health Organization

Result Analysis
Print
Save
E-mail